Document is current

Article History

Received: 11 September 2025

Accepted: 27 November 2025

First Online: 16 January 2026

Declarations

:

: This work did not involve research on humans. The manuscript summarizes the findings from two meetings (MM Health Equity Summits) attended by experts on the topic from various perspectives, including treating physicians, patient advocacy groups, as well as patients living with the disease. The participants discussed the topic reported in this work during the meetings, which were not related to any clinical trial and no intervention was used. Pfizer helped organize the meeting; however, none of the patients who participated in the meetings had enrolled in any Pfizer-sponsored clinical trial. Furthermore, since there was no collection of patient data and the individual experiences were not identifiable, ethical approval was not required per federal regulations 45 CFR 46.104(d).

: All participants consented to participate in the summits.

: OG , JO , PP , AD , LO-R , and EG report no conflicts of interest; RS and ES report employment at and stock ownership with Pfizer; BB reports consultancy role for AbbVie, Janssen, Kite Pharmaceuticals, Oncopeptides, Pfizer, and Takeda.